- Sections
- C - Chimie; métallurgie
- C07D - Composés hétérocycliques
- C07D 285/135 - Atomes d'azote
Détention brevets de la classe C07D 285/135
Brevets de cette classe: 263
Historique des publications depuis 10 ans
|
25
|
23
|
22
|
26
|
19
|
15
|
17
|
13
|
9
|
2
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2961 |
10 |
| Bristol-myers Squibb Company | 5080 |
5 |
| Boehringer Ingelheim International GmbH | 4629 |
5 |
| Abbott Laboratories | 2542 |
5 |
| FUJIFILM Corporation | 27102 |
5 |
| Calithera Biosciences, Inc. | 52 |
5 |
| Kyowa Hakko Kogyo Co., Ltd. | 127 |
5 |
| Plexxikon Inc. | 168 |
5 |
| Sanofi | 3836 |
5 |
| The Regents of the University of California | 18943 |
4 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 1906 |
4 |
| Romark Laboratories L.C. | 60 |
4 |
| Lead Pharma Holding B.V. | 27 |
4 |
| Servier Pharmaceuticals, LLC | 95 |
4 |
| Vivoryon Therapeutics N.V. | 41 |
4 |
| Novartis AG | 11238 |
3 |
| Board of Regents, The University of Texas System | 5370 |
3 |
| The Johns Hopkins University | 5377 |
3 |
| Vertex Pharmaceuticals Incorporated | 1581 |
3 |
| Purdue Research Foundation | 3277 |
3 |
| Autres propriétaires | 174 |